Android Apple

Institutional investors may adopt severe steps after Harvard Bioscience, Inc.'s (NASDAQ:HBIO) latest 13% drop adds to a year losses

By Yahoo! Finance   |   4 months ago
Institutional investors may adopt severe steps after Harvard Bioscience, Inc.'s (NASDAQ:HBIO) latest 13% drop adds to a year losses

Institutional investors hold 65% of Harvard Bioscience, Inc. (NASDAQ:HBIO), influencing stock dynamics. Top 10 investors own 52%, with hedge funds and CEO James Green also holding significant stakes.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.